FSFrank Steigerwald

Frank Steigerwald

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frank Steigerwald has a total of 202 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long‐Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10‐Year Follow‐Up

    by Patricia Krause, Philipp Mahlknecht, Inger Marie Skogseid, Frank Steigerwald, Günther Deuschl, Richard Erasmi, Alfons Schnitzler, Tobias Warnecke, Jörg Müller, Werner Poewe, et al.

    Background: Pallidal neurostimulation is an effective treatment for severe isolated dystonia, but long‐term data from clinical trials are lacking.Objectives: To evaluate long‐term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.Methods: Extension study of the prospective multicenter trial (n = 40; July 2002 to May 2004), all patients received effective stimulation and underwent regular follow‐up. The 10‐year follow‐up (n = 31) included Burke–Fahn–Marsden Dystonia Rating Scale (BFMDRS) motor and disability score, Beck Depression Inventory, Beck Anxiety Inventory, and Mattis Dementia Rating Scale. Primary and secondary endpoints compared motor symptoms, disability scores, mood, and cognition changes.Results: Thirty‐one patients (12 female), aged 23–72 years, completed the 10‐year study extension. Per protocol analysis showed sustained significant improvement in BFMDRS motor scores at 10 years compared with baseline, without significant change from the 6‐month or 5‐year follow‐up. On average, motor scores decreased by 25.3 ± 5.2 points at 10 years (P < 0.0001; 56% improvement). Individual outcomes varied, with 27 responders (≥25% improvement; mean improvement 65.2 ± 21.4%) and 13 non‐responders compared with baseline. Sustained improvements were seen in disability, mood, and anxiety scores. Cognition remained stable.Conclusions: This study presents the longest prospective, multicenter follow‐up of pallidal neurostimulation in generalized and segmental dystonia. Two‐thirds of patients showed strong and stable long‐term improvements of dystonia, confirming sustained efficacy and safety over 10 years in treatment‐refractory dystonic patients. However, one‐third experienced primary (3/40) or secondary (10/40) treatment failure. Diagnostic advances, including genetic testing, and technological progress in pallidal neurostimulation may help to reduce the non‐responder rates in the future. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.


  • Open Access

    Evaluation of a programming algorithm for deep brain stimulation in dystonia used in a double-blind, sham-controlled multicenter study

    by for the DBS study group for dystonia, Frank Steigerwald, Anna Dalal Kirsch, Andreas Kupsch, Joerg Mueller, Wilhelm Eisner, Günther Deuschl, Daniela Falk, Alfons Schnitzler, Inger Marie Skogseid, et al.

    Background: Programming deep brain stimulation in dystonia is difficult because of the delayed benefits and absence of evidence-based guidelines. Therefore, we evaluated the efficacy of a programming algorithm applied in a double-blind, sham-controlled multicenter study of pallidal deep brain stimulation in dystonia. Methods: A standardized monopolar review to identify the contact with the best acute antidystonic effect was applied in 40 patients, who were then programmed 0.5 V below the adverse effect threshold and maintained on these settings for at least 3 months, if tolerated. If no acute effects were observed, contact selection was based on adverse effects or anatomical criteria. Three-year follow-up data was available for 31 patients, and five-year data for 32 patients. The efficacy of the algorithm was based on changes in motor scores, adverse events, and the need for reprogramming. Results: The mean (±standard deviation) dystonia motor score decreased by 73 ± 24% at 3 years and 63 ± 38% at 5 years for contacts that exhibited acute improvement of dystonia (n = 17) during the monopolar review. Contacts without acute benefit improved by 58 ± 30% at 3 years (n = 63) and 53 ± 31% at 5 years (n = 59). Interestingly, acute worsening or induction of dystonia/dyskinesia (n = 9) correlated significantly with improvement after 3 years, but not 5 years. Conclusions: Monopolar review helped to detect the best therapeutic contact in approximately 30% of patients exhibiting acute modulation of dystonic symptoms. Acute improvement, as well as worsening of dystonia, predicted a good long-term outcome, while induction of phosphenes did not correlate with outcome. Trial registration: ClinicalTrials.gov NCT00142259.


  • Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry

    by Kirsten Haas, Stephanie Stangl, Frank Steigerwald, Cordula Matthies, Doreen Gruber, Andrea A. Kühn, Joachim K. Krauss, Friederike Sixel-Döring, Kajetan von Eckardstein, Günther Deuschl, et al.


  • Retinal changes in Parkinson's disease and glaucoma

    by Juliane Matlach, Martin Wagner, Uwe Malzahn, Irene Schmidtmann, Frank Steigerwald, Thomas Musacchio, Jens Volkmann, Franz Grehn, Winfried Göbel, Stephan Klebe


  • Open Access

    Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects

    by Anna Dalal Kirsch, Sharon Hassin-Baer, Cordula Matthies, Jens Volkmann, Frank Steigerwald


  • Directional Deep Brain Stimulation

    by Frank Steigerwald, Cordula Matthies, Jens Volkmann


  • Open Access

    Pulse duration settings in subthalamic stimulation for Parkinson's disease

    by Frank Steigerwald, Lars Timmermann, Andrea Kühn, Alfons Schnitzler, Martin M. Reich, Anna Dalal Kirsch, Michael Thomas Barbe, Veerle Visser‐Vandewalle, Julius Hübl, Christoph van Riesen, et al.

    Background: Stimulation parameters in deep brain stimulation (DBS) of the subthalamic nucleus for Parkinson's disease (PD) are rarely tested in double‐blind conditions. Evidence‐based recommendations on optimal stimulator settings are needed. Results from the CUSTOM‐DBS study are reported, comparing 2 pulse durations.Methods: A total of 15 patients were programmed using a pulse width of 30 µs (test) or 60 µs (control). Efficacy and side‐effect thresholds and unified PD rating scale (UPDRS) III were measured in meds‐off (primary outcome). The therapeutic window was the difference between patients’ efficacy and side effect thresholds.Results: The therapeutic window was significantly larger at 30 µs than 60 µs (P = ·0009) and the efficacy (UPDRS III score) was noninferior (P = .00008).Interpretation: Subthalamic neurostimulation at 30 µs versus 60 µs pulse width is equally effective on PD motor signs, is more energy efficient, and has less likelihood of stimulation‐related side effects. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.


  • Open Access

    Movement-Related Activity of Human Subthalamic Neurons during a Reach-to-Grasp Task

    by Monika Pötter-Nerger, Rene Reese, Frank Steigerwald, Jan Arne Heiden, Jan Herzog, Christian K. E. Moll, Wolfgang Hamel, Uri Ramirez-Pasos, Daniela Falk, Maximilian Mehdorn, et al.

    The aim of the study was to record movement-related single unit activity in the human subthalamic nucleus (STN) during a standardized motor task of the upper limb. We performed microrecordings from the motor region of the human STN and registered kinematic data in twelve patients with Parkinson’s disease undergoing deep brain stimulation surgery (seven women, mean age 62.0 ± 4.7 years) while they intraoperatively performed visually cued reach-to-grasp movements using a grip device. Single unit activity was analyzed offline in relation to different aspects of the movement (attention, start of the movement, movement velocity, button press) in terms of firing frequency, firing pattern, and oscillation. During the reach-to-grasp movement, 75/114 isolated subthalamic neurons exhibited movement-related activity changes. The largest proportion of single units showed modulation of firing frequency during several phases of the reach and grasp (polymodal neurons, 45/114), particularly an increase of firing rate during the reaching phase of the movement, which often correlated with movement velocity. The firing pattern (bursting, irregular, or tonic) remained unchanged during movement compared to rest. Oscillatory single unit firing activity (predominantly in the theta and beta frequency) decreased with movement onset, irrespective of oscillation frequency. This study shows for the first time specific, task-related, single unit activity changes during the reach-to-grasp movement in humans.


  • Open Access

    Directional leads for deep brain stimulation: Opportunities and challenges

    by W. M. Michael Schüpbach, Stéphan Chabardes, Cordula Matthies, Claudio Pollo, Frank Steigerwald, Lars Timmermann, Veerle Visser Vandewalle, Jens Volkmann, P. Richard Schuurman


  • Open Access

    Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson’s Disease

    by Andrea Canessa, Nicolò G. Pozzi, Gabriele Arnulfo, Joachim Brumberg, Martin M. Reich, Gianni Pezzoli, Maria F. Ghilardi, Cordula Matthies, Frank Steigerwald, Jens Volkmann, et al.

    Activation of the basal ganglia has been shown during the preparation and execution of movement. However, the functional interaction of cortical and subcortical brain areas during movement and the relative contribution of dopaminergic striatal innervation remain unclear. We recorded local field potential activity from the subthalamic nucleus and high-density electroencephalography signals in four patients with Parkinson’s disease off dopaminergic medication during a multi-joint motor task performed with their dominant and non-dominant hand. Recordings were performed by means of a fully-implantable deep brain stimulation device at four months after surgery. Three patients also performed a single-photon computed tomography with [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane to assess striatal dopaminergic innervation. Unilateral movement execution led to event-related desynchronization followed by a rebound after movement termination (event-related synchronization) of oscillatory beta activity in the subthalamic nucleus and primary sensorimotor cortex of both hemispheres. Dopamine deficiency directly influenced movement-related beta-modulation, with greater beta-suppression in the most dopamine-depleted hemisphere for both ipsi- and contralateral hand movements. Cortical-subcortical, but not interhemispheric subcortical coherencies were modulated by movement and influenced by striatal dopaminergic innervation, being stronger in the most dopamine-depleted hemisphere. The data are consistent with a role of dopamine in shielding subcortical structures from an excessive cortical entrapment and cross-hemispheric coupling, thus allowing fine-tuning of movement.